Kelly Trowhill, LLMFT, MAFPc

03/13/2025

https://x.com/SBakerMD/status/1900233163605238239

02/26/2025

https://link.springer.com/article/10.1007/s10597-024-01255-w

People who take antipsychotics, and people who are prescribed antipsychotics without taking them, experience effects which are not frequently discussed: effects on their identity and sense of self. Qualitative research indicates the relationship between taking APs and identity is multilayered, and c...

02/26/2025

https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-03851-3

Background Dementia is associated with psychiatric symptoms but the effects of antidepressants on cognitive function in dementia are understudied. We aimed to investigate the association between antidepressants and cognitive decline in patients with dementia, and the risk of severe dementia, fractur...

02/24/2025

https://t.co/gZyruFalED

02/18/2025

https://www.madinamerica.com/2025/02/why-our-beliefs-about-mental-illness-are-making-stigma-worse/

A new study finds that biological explanations for mental illness are linked to increased stigma, while attributing struggles to sociopolitical turmoil reduces it.

02/15/2025

Eli Lilly hid many of their Prozac-related su***de attempts under false categories. The drug company failed to inform the FDA that it was recoding reported su***des and su***de attempts in order to disguise them as less serious adverse events.

SSRIs were FDA approved "safe and effective" fraudulently.

In-house Eli Lilly memoranda by Claude Bouchy written in November 1990 showing that the company consciously hid Prozac-induced suicidal acts under misleading categories, such as "no drug effect," so that they remained undisclosed by the FDA.

In one memo, Eli Lilly employee expresses shame and regret about hiding this data.

Numerous sources have now expressed public concern about Eli Lilly seemingly withheld documents concerning Prozac-induced activation (stimulation), suicidality and aggression.

The drug company was aware their SSRI was causing akathisia and mislabeled it as "agitation" and "activation" and never published that 38% of subjects who were given the drug experienced akathisia.

Instead, subjects were given sedatives like Va**um against the rules of these studies as approved by the FDA.

Benzodiazepines temporarily suppressed some of the activation/akathisia symptoms in many patients.

Eli Lilly also purposely unreported subjects who experienced Prozac-induced mania and hypomania.
9:05 AM · Feb 14, 2025
·
3,536
Views

02/12/2025

https://www.madintheuk.com/2025/02/wishful-thinking-dressed-up-in-scientific-terminology-a-reply-to-awais-aftab/

Professor Joanna Moncrieff replies to the criticism levelled at her new book Chemically Imbalanced by Awais Aftab

02/05/2025

Dr Joanna Moncrieff

·
2h
This 2019 paper debunks most of these claims and concludes 'there is a lack of evidence for leading biological theories for onset and maintenance of depression'

Leading biological hypotheses propose that biological changes may underlie major depressive disorder onset and relapse/recurrence. Here, we investigate if there is prospective evidence for biomarkers derived from leading theories. We focus on ...

02/04/2025

Matt Walsh

The ADHD Parenting subreddit is a horror show. Diagnosing a four year old with a mental disorder and giving him drugs because he’s “impulsive” is absolute insanity. Every four year old in the world is impulsive. If you’re having trouble controlling him, that’s a parenting issue. He’s not mentally disordered. He’s four.

01/22/2025

Daniel Owens

The harm caused by the chemical imbalance theory

Being told they have a chemical imbalance makes patients less resilient, more pessimistic about recovery, and more likely to take medication.

Evidence also suggests that being informed of a chemical imbalance does not reduce patients' self-blame—a key justification often cited by psychiatrists for promoting the theory.

If promoting this falsified theory convinces patients to take antidepressants while simultaneously causing such harmful effects, whose interests is the chemical imbalance theory truly serving—the patient's or the clinician's?

Source: Kemp, J.J., Lickel, J.J., & Deacon, B.J. (2014). Effects of a chemical imbalance causal explanation on individuals’ perceptions of their depressive symptoms. Behaviour Research and Therapy, 56, 47–52

01/15/2025

Dr. Roger McFillin

How does the brain react to an SSRI? By shutting down the release of serotonin & by reducing the number of receptors that can respond to serotonin- creating brain dysfunction. Ask people who have tried to get off these drugs how they feel.
It’s not correcting a chemical imbalance… ITS INDUCING ONE!

01/14/2025